Kemira Oyj
Stock exchange release
April 28, 2011 at 5.00 pm (CET+1)
Kemira Oyj has today received a summons where it is stated that Cartel Damage Claims Hydrogen Peroxide SA (CDC) claims charges up to EUR 78 million and including interest and litigation expenses from Kemira Oyj for violations against competition law in hydrogen peroxide business. Kemira is processing the summons document.
The referred violations of competition law are the same as those on basis of which CDC has taken legal action in Germany in Dortmund. Kemira published a stock exchange release on the issue on August 19, 2009. Kemira defends against the claim.
For more information, please contact
Kemira Oyj
Jukka Hakkila, Group General Counsel
Tel. +358 10 862 1690
Tero Huovinen, Director, Investor Relations
Tel. +358 10 862 1980
Kemira is a global two billion euro chemicals company that is focused on serving customers in water-intensive industries. The company offers water quality and quantity management that improves customers’ energy, water, and raw material efficiency. Kemira’s vision is to be a leading water chemistry company.